Pheochromocytoma Paraganglioma clinical trials

Explore recruiting pheochromocytoma paraganglioma clinical trials.

Recruiting pheochromocytoma paraganglioma studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Pheochromocytoma Paraganglioma trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Multicenter, Open-label, Phase 3 Extension Study to Evaluate the Long‑term Efficacy and Safety in Participants Who Are Currently on Treatment in a Belzutifan Study (LITESPARK-043)

Czechia, Spain, Poland, Belgium, Finland, Germany +4 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Pheochromocytoma Paraganglioma trials by city

Pheochromocytoma Paraganglioma in Toronto Pheochromocytoma Paraganglioma in Vancouver Pheochromocytoma Paraganglioma in Montreal Pheochromocytoma Paraganglioma in Calgary Pheochromocytoma Paraganglioma in Edmonton Pheochromocytoma Paraganglioma in Ottawa Pheochromocytoma Paraganglioma in Winnipeg Pheochromocytoma Paraganglioma in Quebec City Pheochromocytoma Paraganglioma in Hamilton Pheochromocytoma Paraganglioma in Kitchener Pheochromocytoma Paraganglioma in London Pheochromocytoma Paraganglioma in Halifax Pheochromocytoma Paraganglioma in New York Pheochromocytoma Paraganglioma in Los Angeles Pheochromocytoma Paraganglioma in Chicago Pheochromocytoma Paraganglioma in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease